(Q34566571)

3 August 2017

1 reference

title

New developments in animal models of Alzheimer's disease (English)

1 reference

3 August 2017

0 references

Janus C

1

1 reference

3 August 2017

Phinney AL

series ordinal

2

1 reference

3 August 2017

Chishti MA

series ordinal

3

1 reference

3 August 2017

Westaway D

series ordinal

4

1 reference

3 August 2017

publication date

1 September 2001

1 reference

Current Neurology and Neuroscience Reports

3 August 2017

published in

1 reference

3 August 2017

volume

1

1 reference

3 August 2017

issue

5

1 reference

3 August 2017

page(s)

451-457

1 reference

https://scigraph.springernature.com/pub.10.1007/s11910-001-0105-8

3 August 2017

exact match

0 references

cites work

Presenilin structure, function and role in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1007%2FS11910-001-0105-8

Biochemical detection of Abeta isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-001-0105-8

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-001-0105-8

Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-001-0105-8

Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-001-0105-8

Transgenic mouse models of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-001-0105-8

Brain trauma in aged transgenic mice induces regression of established abeta deposits

21 January 2018

1 reference

12 December 2020

Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

1 reference

12 December 2020

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

1 reference

12 December 2020

Antibody clears senile plaques

1 reference

12 December 2020

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

1 reference

12 December 2020

Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes

1 reference

12 December 2020

A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease

1 reference

12 December 2020

Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3.

1 reference

12 December 2020

Alzheimer's disease: model behaviour.

1 reference

12 December 2020

Assembly of paired helical filaments from mouse tau: implications for the neurofibrillary pathology in transgenic mouse models for Alzheimer's disease

1 reference

12 December 2020

Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models

1 reference

12 December 2020

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

1 reference

12 December 2020

Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid beta-peptide deposition in homozygous APP(V717F) transgenic mice.

1 reference

12 December 2020

Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration

1 reference

12 December 2020

A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1.

1 reference

12 December 2020

Characterization of pathology in transgenic mice over-expressing human genomic and cDNA tau transgenes

1 reference

12 December 2020

Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice.

1 reference

12 December 2020

Single and multiple transgenic mice as models for Alzheimer's disease

1 reference

12 December 2020

Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity

1 reference

12 December 2020

Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease

1 reference

12 December 2020

A stop-codon mutation in the BRI gene associated with familial British dementia

1 reference

12 December 2020

Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation.

1 reference

12 December 2020

Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695.

1 reference

12 December 2020

Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain

1 reference

12 December 2020

Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice

1 reference

12 December 2020

Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5

1 reference

12 December 2020

Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE

1 reference

12 December 2020

Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein

1 reference

12 December 2020

A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor

1 reference

12 December 2020

1 reference

12 December 2020

Behavioral disturbances in transgenic mice overexpressing the V717F beta-amyloid precursor protein.

1 reference

12 December 2020

Genetic modification of the phenotypes produced by amyloid precursor protein overexpression in transgenic mice.

1 reference

12 December 2020

Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease.

1 reference

12 December 2020

Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology

1 reference

12 December 2020

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

12 December 2020

Cognitive and neurobiologic markers of early Alzheimer disease

1 reference

12 December 2020

Neuron loss in APP transgenic mice

1 reference

12 December 2020

Spatial learning in transgenic mice expressing human presenilin 1 (PS1) transgenes.

1 reference

12 December 2020

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

1 reference

12 December 2020

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

1 reference

12 December 2020

Glycogen synthase kinase-3beta phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice.

1 reference

12 December 2020

Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline

1 reference

12 December 2020

Transgenic mouse models of Alzheimer's disease

1 reference

12 December 2020

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

1 reference

12 December 2020

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease

1 reference

12 December 2020

10.1007/S11910-001-0105-8

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

1033692653

0 references

1 reference